Revolutionizing access to life-changing drugs
We redesign processes and integrate innovative technologies for faster, cheaper, and simpler biotech drug production and development. This allows more people to get the life-changing vaccines and therapies they need.
Our transformative impact:
Time
%
Reduction in drug development timelines
Cost
%
Reduction in RNA drug development cost
Our Platforms
Our journey into new markets has led us to recognize the need for tailored solutions that address unique regulatory, manufacturing, and timeline requirements.
Our commitment to innovation is driving the development of next-generation design-to-delivery platforms. These integrated systems encompass the entire manufacturing process, resulting in ready-to-use drug solutions.
By focusing on integration and streamlining processes, we are significantly reducing manufacturing timelines while ensuring compliance and efficiency.
Through our dedication to innovation, we're creating technologies that empower industries to produce life-saving products faster and more cost-effectively than ever before.
Design
Bioinformatics platform that streamlines the RNA sequence design and optimization.
We have tackled the challenge of mRNA complex design by developing a bioinformatic platform that streamlines the RNA sequence design and optimization.
We can:
-
Design highly functional RNA for diverse applications.
Enhance the biological performance according to the foreseen use.
De-risk the development by reducing development timelines and associated costs.
Univercells fills a critical gap in RNA in silico design, enabling faster, more affordable drug development with better performances and lower doses.
DNA
Translate designed RNA sequence into a DNA template with proprietary cell-free enzymatic amplification.
Univercells bridges the gap between RNA in silico design and DNA production.
We translate the designed RNA sequence into a DNA template (crucial starting point for RNA manufacturing) by leveraging our proprietary cell-free enzymatic method.
-
AMPLIFICATION EFFICIENCY
Amplifying your plasmid DNA template containing the gene of interest, delivering ideally suited linear DNA for mRNA synthesis.
SPEED
Our services can deliver DNA in weeks, compared to traditional methods that can take up to months.
SAFETY
Our processes eliminates risks linked to traditional E. Coli production. Including the absence of biological contaminants, reduced risk of unwanted bacterial sequences in the final product, and the elimination of residual E.coli genomic DNA and proteins.
RNA
Construct-agnostic process for mRNA production, compatible with portfolio of scalable manufacturing technologies. Validating for other RNA chemistries.
We tackled the expensive and complex mRNA production using a proprietary process and manufacturing technology.
Our process is:
-
OPTIMISED
Minimizing reagent consumption for equivalent output.
AGNOSTIC
High-yield, consistent quality regardless of RNA construct.
SCALABLE
Our continuous, automated production in a compact system enables efficient large-scale production without the necessity of increasing reaction volumes.
HAVE LIMITED FOOTPRINT
Our compact technology can fit in a space as compact as a shipping container.
Delivery
Proprietary lipids and compositions for formulation, novel delivery systems including viruses for effective drug delivery.
We deliver effective mRNA vaccines through a dual approach:
-
Technological development – LNPs encapsulation
Providing predictable scaling, automated equipment, and reduces the need for investment due to its compact design.
Formulation development – novel delivery systems
We are developing new formulations (LNP, non-LNPs and hybrids) to address limitations such as reactogenicity, thermostability, associated with current LNP systems.
Our Pipeline
Partners
We cultivate strong partnerships, recognizing that a robust network is essential to accelerate drug development and access to patients.
We believe the future of competition is collaboration.
We partner with research institutes....
We strategically partner with research institutes, granting us proximity to cutting-edge research and enabling us to support the development of future drugs.
Together with biotechs...
We drive innovation in new therapies development. We establish win-win situations by leveraging our technology to manufacture new drugs, accelerating their path to patients.
Our network extends to Big Pharma.
Big pharmaceutical companies bring their extensive drug development expertise and established market access, while Univercells provides innovative manufacturing solutions.
Co-development partner for accelerated development of personalized cancer vaccines based on our proprietary platform.
Technology supplier for the World Health Organization mRNA vaccine technology transfer hub.
Partner to accelerate African vaccine manufacturing autonomy and sustainability, including affordable access to mRNA-based epidemic vaccines and Measles-Rubella vaccines for routine immunization in Africa.
Long-term partner for developing and manufacturing next generation vaccines for neglected tropical diseases, for supply within Latin America and across the world.
Technology supplier and collaborator on mRNA production, novel technologies for affordable and safe vaccine scale up and vaccine candidate development.